Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $70.00 at HC Wainwright

Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target upped by HC Wainwright from $57.00 to $70.00 in a report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the stock. Needham & Company LLC boosted their price objective […]

Mar 3, 2025 - 07:54

Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target upped by HC Wainwright from $57.00 to $70.00 in a report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the stock. Needham & Company LLC boosted their price objective […]